agilon health Stock Price, News & Analysis (NYSE:AGL)

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.

9 analysts have issued twelve-month price targets for agilon health's shares. Their AGL share price targets range from $12.00 to $32.00. On average, they expect the company's stock price to reach $22.09 in the next year. This suggests a possible upside of 91.3% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

agilon health's stock was trading at $16.14 at the start of the year. Since then, AGL stock has decreased by 28.4% and is now trading at $11.55.
View the best growth stocks for 2023 here.

agilon health saw a increase in short interest in November. As of November 15th, there was short interest totaling 49,330,000 shares, an increase of 6.4% from the October 31st total of 46,380,000 shares. Based on an average daily volume of 2,770,000 shares, the days-to-cover ratio is presently 17.8 days. Approximately 16.4% of the company's stock are sold short.
View agilon health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 6th 2024.
View our AGL earnings forecast.

agilon health, inc. (NYSE:AGL) announced its earnings results on Thursday, November, 2nd. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.01. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.14 billion. agilon health had a negative trailing twelve-month return on equity of 8.18% and a negative net margin of 2.11%.

ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Fidelity Disruptive Medicine ETF (FMED), iShares U.S. Healthcare Providers ETF (IHF), Renaissance IPO ETF (IPO), Fidelity Growth Opportunities ETF (FGRO) and Global X Aging Population ETF (AGNG).RiverNorth Patriot ETF (FLDZ) and

(AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Morgan Stanley (11.04%), Wellington Management Group LLP (10.18%), Rock Springs Capital Management LP (2.04%), Artisan Partners Limited Partnership (1.68%), Brown Advisory Inc. (0.98%) and Charles Schwab Investment Management Inc. (0.44%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai.
View institutional ownership trends.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.